BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30851886)

  • 1. The prognostic value of a Surgical Outcome Risk Tool in patients after radical gastrectomy for gastric cancer and its guiding significance for postoperative chemotherapy.
    Tu RH; Lin JX; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Surg Oncol; 2019 Mar; 28():128-134. PubMed ID: 30851886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery.
    Coimbra FJF; de Jesus VHF; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Felismino T; Mello CAL; Almeida MF; Begnami MDFS; Dias-Neto E; Riechelmann RSP; da Costa WL
    Ann Surg Oncol; 2019 Oct; 26(11):3618-3626. PubMed ID: 31222685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification.
    Wei J; Yao T; Wang Y; Li L; Pan C; Zhang N
    Clin Transl Oncol; 2019 Feb; 21(2):232-238. PubMed ID: 29968135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study.
    Chen L; Zhang C; Yao Z; Cui M; Xing J; Yang H; Zhang N; Liu M; Xu K; Tan F; Li Y; Jiang B; Su X
    BMC Cancer; 2021 Aug; 21(1):974. PubMed ID: 34461860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
    Peng L; Yang W; Zhang Z; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea.
    Jo JC; Baek JH; Koh SJ; Kim H; Min YJ; Lee BU; Kim BG; Jeong ID; Cho HR; Kim GY
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):282-7. PubMed ID: 25856172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term outcome and analysis of prognostic factors in 114 cases of postoperative stage III gastric cancer].
    Zhang Y; Ma LW
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):863-6. PubMed ID: 24447487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of anaemia in oesophago-gastric cancer patients undergoing curative treatment by means of neoadjuvant chemotherapy and surgery.
    Chan BY; McKinlay S; Forshaw M; MacDonald A; Maitra R; Orizu M; McSorley ST
    Surg Oncol; 2021 Sep; 38():101585. PubMed ID: 33930843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?
    Lee KG; Lee HJ; Oh SY; Yang JY; Ahn HS; Suh YS; Kong SH; Kim TY; Oh DY; Im SA; Lee KU; Kim WH; Bang YJ; Yang HK
    Ann Surg Oncol; 2016 Apr; 23(4):1234-43. PubMed ID: 26597366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma.
    Farrow NE; Freischlag KW; Adam MA; Blazer DG
    J Surg Oncol; 2020 Mar; 121(3):486-493. PubMed ID: 31919862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
    In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
    Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.
    Vicente D; Ikoma N; Chiang YJ; Fournier K; Tzeng CD; Song S; Mansfield P; Ajani J; Badgwell BD
    Ann Surg Oncol; 2018 Sep; 25(9):2720-2730. PubMed ID: 29987602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.
    Hwang JE; Hong JY; Kim JE; Shim HJ; Bae WK; Hwang EC; Jeong O; Park YK; Lee KH; Lee JH; Cho SH; Chung IJ
    Jpn J Clin Oncol; 2015 Jun; 45(6):541-6. PubMed ID: 25759484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
    Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
    World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
    Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J
    World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy.
    Nakamura Y; Yamanaka T; Chin K; Cho H; Katai H; Terashima M; Misawa K; Hirao M; Yoshida K; Oki E; Sasako M; Emi Y; Bando H; Kawashima Y; Fukunaga T; Gotoh M; Ishibashi T; Shitara K
    Ann Surg Oncol; 2019 Feb; 26(2):465-472. PubMed ID: 30456678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy
    Li Y; Ma FH; Xue LY; Tian YT
    World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.